{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:26:18Z","timestamp":1773854778897,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.xphs.2016.01.023","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T07:33:23Z","timestamp":1457768003000},"page":"2760-2769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hyaluronic Acid-Based Biocompatible Supramolecular Assembly for Sustained Release of Antiretroviral Drug"],"prefix":"10.1016","volume":"105","author":[{"given":"Byeongwoon","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Pusk\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lajos","family":"Szente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.K.","family":"Hildreth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2016.01.023_bib1","first-page":"1001","article-title":"Polymeric nanoparticles for targeted treatment in oncology: current insights","volume":"10","author":"Prabhu","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2016.01.023_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.021","article-title":"Nanoparticles\u2014a historical perspective","volume":"331","author":"Kreuter","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.01.023_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","article-title":"Hyaluronan: its nature, distribution, functions and turnover","volume":"242","author":"Fraser","year":"1997","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.xphs.2016.01.023_bib4","doi-asserted-by":"crossref","first-page":"17768","DOI":"10.1016\/S0021-9258(18)45445-2","article-title":"Cartilage proteoglycan aggregates. The link protein and proteoglycan amino-terminal globular domains have similar structures","volume":"262","author":"Neame","year":"1987","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2016.01.023_bib5","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1021\/nn204123p","article-title":"In situ supramolecular assembly and modular modification of hyaluronic acid hydrogels for 3D cellular engineering","volume":"6","author":"Park","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.xphs.2016.01.023_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11481-014-9576-7","article-title":"Amphiphilic cationic nanogels as brain-targeted carriers for activated nucleoside reverse transcriptase inhibitors","volume":"10","author":"Warren","year":"2015","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.xphs.2016.01.023_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.arcmed.2014.11.020","article-title":"Cyclodextrins, blood-brain barrier, and treatment of neurological diseases","volume":"45","author":"Vecsernyes","year":"2014","journal-title":"Arch Med Res"},{"key":"10.1016\/j.xphs.2016.01.023_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nbt0612-471","article-title":"Proof of concept for next-generation nanoparticle drugs in humans","volume":"30","author":"Sheridan","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.xphs.2016.01.023_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/088922203322280900","article-title":"Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells","volume":"19","author":"Liao","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.xphs.2016.01.023_bib10","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/00002030-200211220-00004","article-title":"Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity","volume":"16","author":"Campbell","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.xphs.2016.01.023_bib11","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1128\/JVI.77.15.8237-8248.2003","article-title":"Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts","volume":"77","author":"Graham","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.xphs.2016.01.023_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1039\/b100916h","article-title":"Heparin and heparan sulfate: structure and function","volume":"19","author":"Rabenstein","year":"2002","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.xphs.2016.01.023_bib13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/asia.201301391","article-title":"Supramolecular proteoglycan aggregate mimics: cyclodextrin-assisted biodegradable polymer assemblies for electrostatic-driven drug delivery","volume":"9","author":"Szente","year":"2014","journal-title":"Chem Asian J"},{"key":"10.1016\/j.xphs.2016.01.023_bib14","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2016.01.023_bib15","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1128\/AAC.48.5.1652-1663.2004","article-title":"Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription","volume":"48","author":"Kutsch","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2016.01.023_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.virol.2004.02.001","article-title":"Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease","volume":"322","author":"Song","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.xphs.2016.01.023_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(99)00326-9","article-title":"Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrins","volume":"193","author":"Mura","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.01.023_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1006\/abbi.1993.1311","article-title":"Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction","volume":"303","author":"Berridge","year":"1993","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.xphs.2016.01.023_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpba.2011.05.005","article-title":"Characterization of drug-cyclodextrin formulations using Raman mapping and multivariate curve resolution","volume":"56","author":"Vajna","year":"2011","journal-title":"J\u00a0Pharm Biomed Anal"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T01:20:11Z","timestamp":1655256011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0022354916003233"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.01.023","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic Acid-Based Biocompatible Supramolecular Assembly for Sustained Release of Antiretroviral Drug","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}